OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
113
Results
Show all
Save search
Copy query
Show results for
Unknown
(113)
Publication Date
Release Date
2021
(24)
2024
(16)
2022
(14)
2023
(12)
2025
(9)
2018
(9)
2026
(5)
2015
(4)
2014
(4)
2019
(3)
2017
(3)
2020
(2)
2008
(2)
2016
(1)
2013
(1)
2012
(1)
2011
(1)
2010
(1)
2006
(1)
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
Anaesthesia Choice for Creation of Arteriovenous Fistula (ACCess) study protocol : a randomised controlled trial comparing primary unassisted patency at 1 year of primary arteriovenous fistulae created under regional compared to local anaesthesia.
Not available
S-EPMC8704953
|
biostudies-literature
Cite
Why Lyme disease is common in the northern US, but rare in the south: The roles of host choice, host-seeking behavior, and tick density.
Not available
S-EPMC7842935
|
biostudies-literature
Cite
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
Not available
S-EPMC9177850
|
biostudies-literature
Cite
Accelarated immune ageing is associated with COVID-19 disease severity.
Not available
S-EPMC10782727
|
biostudies-literature
Cite
Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study.
Not available
S-EPMC4578796
|
biostudies-literature
Cite
Towards cascading genetic risk in Alzheimer's disease.
Not available
S-EPMC11292901
|
biostudies-literature
Cite
Enhancing cognitive performance prediction by white matter hyperintensity connectivity assessment.
Not available
S-EPMC11629703
|
biostudies-literature
Cite
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.
Not available
S-EPMC4380721
|
biostudies-literature
Cite
The Toxicology Investigators Consortium 2020 Annual Report.
Not available
S-EPMC8447896
|
biostudies-literature
Cite
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment.
Not available
S-EPMC8113113
|
biostudies-literature
Cite
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets